内部人交易记录
首席财务官基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by McClung David, 首席财务官. Director active across 1 company, notably BioCardia, Inc.. Aggregated, 16 filings have been recorded. Split: 3 buys · 0 sell. Total volume traded: €35k. History available since 10 June 2021. The latest transaction was filed on 2 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McClung David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
23,125 股@ US$1.240.16% mcap6.5% 占其流量Common StockSEC:0001437749-26-022968:0
60,483 股Common StockSEC:0001437749-26-022364:0
58,276 股@ US$1.3715.6% 占其流量Common StockSEC:0001437749-25-037474:0
4,819 股@ US$2.0752.3% 占其流量Common StockSEC:0001437749-25-022065:0
13,123 股@ US$1.9056.1% 占其流量Common StockSEC:0001437749-25-013200:0
24,193 股@ US$2.6516.2% 占其流量Common StockSEC:0001437749-24-031410:0
8,333 股@ US$3.006.2% 占其流量Common StockSEC:0001437749-24-028511:0
4,280 股@ US$2.3362.5% 占其流量Common StockSEC:0001437749-23-018552:0
20,676 股@ US$1.779.4% 占其流量Common StockSEC:0001437749-23-016522:0
61,389 股@ US$1.7026.7% 占其流量Common StockSEC:0001437749-23-015516:0
17,347 股@ US$1.326.1% 占其流量Common StockSEC:0001437749-23-009766:0
8,928 股@ US$1.683.9% 占其流量Common StockSEC:0001437749-22-029314:0
2,000 股@ US$2.071.2% 占其流量Common StockSEC:0001437749-22-023876:0
20,632 股@ US$1.320.24% mcap33.5% 占其流量Common StockSEC:0001437749-22-012952:0
50,345 股0Common StockSEC:0001437749-22-009165:0
7,274 股@ US$4.355.9% 占其流量Common StockSEC:0001437749-21-014633:0
About McClung David
McClung David is Directeur Financier at BioCardia, Inc. (XNAS). He has 16 filings in total, and across the recent sample of 16 filings, buys amount to EUR 34817 and sells to EUR 0, with transactions dated from 2021-06-11 to 2026-07-07, and the modal transaction nature is Attribution.